[1] Ginès P, Krag A, Abraldes JG, et al. Liver cirrhosis[J]. Lancet,2021,398:1359-1376.
[2] Casari M, Siegl D, Deppermann C,et al. Macrophages and platelets in liver fibrosis and hepatocellular carcinoma[J]. Front Immunol,2023,14:1277808.
[3] Subramanian P, Chavakis T. The complex function of macrophages and their subpopulations in metabolic injury associated fatty liver disease[J]. J Physiol,2023,601:1159-1171.
[4] Gomez Perdiguero E, Klapproth K, Schulz C, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors[J]. Nature,2015,518:547-551.
[5] Lazarov T, Juarez-Carre?o S, Cox N,et al. Physiology and diseases of tissue-resident macrophages[J]. Nature,2023,618:698-707.
[6] Wang C, Ma C, Gong L, et al. Macrophage Polarization and Its Role in Liver Disease[J]. Front Immunol,2021,12:803037.
[7] Shin AE, Tesfagiorgis Y, Larsen F, et al. F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis[J]. Gastroenterology,2023,164:593-609.?
[8] Kisseleva T, Brenner D.Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol,2021,18:151-166.
[9] 江海燕,钟芳芳,张俊平.肝巨噬细胞与肝纤维化研究进展[J].药学实践与服务,2024,42:135-140.
[10] Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair[J]. J Clin Invest,2005,115:56-65.
[11] Tian T, Zhao C, Li S, et al. Liver-Targeted Delivery of Small Interfering RNA of C-C Chemokine Receptor 2 with Tetrahedral Framework Nucleic Acid Attenuates Liver Cirrhosis[J]. ACS Appl Mater Interfaces,2023,15:10492-10505.
[12] Li W, Chang N, Li L. Heterogeneity and Function of Kuppfer Cells in Liver Injury[J]. Front Immunol,2022,13:940867.
[13] Roth KJ,Copple BL.Role of Hypoxia-Inducible Factors in the Development of Liver Fibrosis[J]. Cell Mol Gastroenterol Hepatol,2015,1:589-597.
[14] Ma PF, Gao CC, Yi J, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice[J]. J Hepatol,2017,67:770-779.
[15] Jiang K, Lu S, Li D, et al. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization[J]. J Gastroenterol,2023,58:894-907.
[16] He M,Chu T,Wang Z,et al. Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis[J]. Front Immunol,2023,14:1147379.
[17] Tao R, Han M, Yuan W, et al. Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis[J]. Int Immunopharmacol,2023,117:109631.
[18] Ma PF, Gao CC, Yi J, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice[J]. J Hepatol,2017,67:770-779.
[19] Roderfeld M. Matrix metalloproteinase functions in hepatic injury and fibrosis[J]. Matrix Biol,2018,68-69:452-462.
[20] Stegner D, van Eeuwijk JMM, Angay O, et al. Thrombopoiesis is spatially regulated by the bone marrow vasculature[J]. Nat Commun,2017,8:127.
[21] Mandel J, Casari M, Stepanyan M, et al. Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation[J]. Int J Mol Sci,2022,23:3868.
[22] Mussbacher M, Brunnthaler L, Panhuber A, et al. Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases[J]. Int J Mol Sci,2021,22:3113.
[23] 赵芯,李晖,邓秀秀,等.抗血小板药物与肝纤维化[J].实用医学杂志,2024,40:1083-1087.
[24] Kodama T, Takehara T, Hikita H, et al. Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice[J]. Gastroenterology,2010,138:2487-2498.
[25] Ikeda N, Murata S, Maruyama T, et al. Platelet-derived adenosine 5'-triphosphate suppresses activation of human hepatic stellate cell: In vitro study[J]. Hepatol Res,2012,42:91-102.
[26] Chauhan A, Adams DH, Watson SP,et al. Platelets: No longer bystanders in liver disease[J]. Hepatology,2016,64:1774-1784.
[27] Polat B, Halici Z, Cadirci E, et al. Liver 5-HT7 receptors: A novel regulator target of fibrosis and inflammation-induced chronic liver injury in vivo and in vitro[J]. Int Immunopharmacol,2017,43:227-235.
[28] 周鑫,王智,何雪茹,等.潜在抗肝纤维化药物与靶点相关信号通路研究进展[J].临床肝胆病杂志,2023,39:2932-2941.
[29] Ghafoory S, Varshney R, Robison T, et al. Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury[J]. Blood Adv,2018,2:470-480.
[30] Yoshida S, Ikenaga N, Liu SB, et al. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice[J]. Gastroenterology,2014,147:1378-1392.
[31] 刘淑青,朱昌鹏,谢渭芬,等.5-羟色胺对肝脏疾病的作用及其机制研究现状[J].国际消化病杂志,2020,40:231-234.
[32] 李慧媛,杨仁池.血小板的免疫调控功能及其在相关疾病中的作用[J].中华微生物学和免疫学杂志,2023,43:654-662.
[33] Ludwig N, Hilger A, Zarbock A,et al.Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation[J]. Cells,2022,11:1957.
[34] Carestia A, Mena HA, Olexen CM, et al. Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Survival of Septic Mice[J].Cell Rep,2019,28:896-908.
[35] Hoeft K, Schaefer GJL, Kim H, et al. Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner[J].Cell Rep,2023,42:112-131.
[36] 张上上,张媛莉.血小板对单核吞噬细胞系统调控机制的研究进展[J].广东医科大学学报,2021,39:499-504.
[37] Alard JE, Ortega-Gomez A, Wichapong K, et al. Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5[J]. Sci Transl Med,2015,7:317ra196.
[38] Von Hundelshausen P, Koenen RR, Sack M, et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium[J]. Blood,2005,105:924-930.
[39] Roderfeld M. Matrix metalloproteinase functions in hepatic injury and fibrosis[J]. Matrix Biol,2018,68-69:452-462.
[40] 李丽萍,屈晨雪,戴菊华,等.血小板糖基化的研究进展[J].临床检验杂志,2017,35:946-948.
[41] Deppermann C, Kratofil RM, Peiseler M, et al. Macrophage galactose lectin is critical for Kuppfer cells to clear aged platelets[J]. J Exp Med,2020,217:e20190723.
[42] Li J, van der Wal DE, Zhu G, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia[J].Nat Commun,2015,6:7737. |
